CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2032
Detailed information
CancerLivER ID2032
Biomarker miR-9-3
Biomarker Name/Symbol (given in Publication)mir9-3
BiomoleculeRNAs
SubjectHuman
Degree of ValidityPredict survival; but not validated on an independent dataset
Experimental ConditionHBV-HCC v/s Normal; Can predict survival of patients
Cancer typeHBV-associated Hepatocellular carcinoma
RegulationUpregulated in the liver cancer cell lines (0.33 fold)
Level of significance p < 0.05
SourceTissue
PMID28322348
Type of BiomarkerPrognostic
PathwayNA
Cohort93 cases of HBV-HCC and 49 cases of adjacent normal controls and liver cancer cell lines (QGY7703, HepG2, and SMMC7721) and QSG7701, a human normal liver cell line.
SensitivityNA
SpecificityNA
AccuracyNA
AUC0.769
DiseaseHuman HBV-HCC
Year of Publication2017
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top